PreClinical Services

SNBL USA is committed to providing clients with quality you expect with your preclinical needs. We are committed to providing service you trust with the turnaround you need.

Nucleic Acid Therapeutics

As a drug class, Nucleic Acid-based Therapeutics represents a diverse spectrum of chemistry, constructs, and delivery options.

Laboratory Services

Blending our strengths, SNBL USA’s laboratory services division represents a powerful resource to extend discovery and development capabilities while still providing superior, individualized service to each client.


Dr. Christopher Carosino Joins SNBL USA’s Study Director Team

Posted on Dec 10, 2014 in Press Release, The Dream Team

We are pleased to announce Christopher Carosino, PhD has recently joined SNBL USA as a Study Director and newest member of the safety assessment team. With more than 10 years of toxicology and research experience, he is a great addition to SNBL USA, complementing existing service and expertise infrastructure. While Dr. Carosino has focused on the field of toxicology over the course of his career training and development, he has overlapping experience with immunology, analytical chemistry, free radical biology, and nanomaterials and targeted expertise in pulmonary and inhalation toxicology....

Read More

Veteran’s Day. Thank you.

Posted on Nov 11, 2014 in The Human Side

Veteran’s Day. Thank you.

To our many veterans, active military members and their families: Thank you for your service, devotion and sacrifice. Your courage helps protect and uphold the many freedoms we enjoy as Americans.  We are proud of you, and humbly grateful.

Read More

New Bispecific Antibody

Posted on Oct 14, 2014 in Collaboration

New Bispecific Antibody

The Center for Cancer Research (CCR) of the National Cancer Institute (NCI)/NIH, headed by Dr. Dimiter S. Dimitrov, and SNBL USA recently conducted a pharmacokinetic study with a bi0specific monoclonal antibody targeting a cancer-related protein, IGF2.

Read More